Business Description
Luye Pharma Group Ltd
SIC : 2834
ISIN : BMG570071099
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.67 | |||||
Debt-to-EBITDA | 4.06 | |||||
Interest Coverage | 1.52 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.06 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.3 | |||||
3-Year EBITDA Growth Rate | -4.4 | |||||
3-Year EPS without NRI Growth Rate | -25.4 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 40.03 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.86 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.94 | |||||
9-Day RSI | 12.34 | |||||
14-Day RSI | 14.61 | |||||
6-1 Month Momentum % | -19.9 | |||||
12-1 Month Momentum % | -27.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 1.21 | |||||
Cash Ratio | 0.75 | |||||
Days Inventory | 151.89 | |||||
Days Sales Outstanding | 105.25 | |||||
Days Payable | 125.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | -4.8 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.44 | |||||
Operating Margin % | 16.75 | |||||
Net Margin % | 8.67 | |||||
FCF Margin % | 25.98 | |||||
ROE % | 4.66 | |||||
ROA % | 2.09 | |||||
ROIC % | 3.62 | |||||
3-Year ROIIC % | -6.2 | |||||
ROC (Joel Greenblatt) % | 21.95 | |||||
ROCE % | 8.72 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 19.36 | |||||
Forward PE Ratio | 12.38 | |||||
PE Ratio without NRI | 25.38 | |||||
Shiller PE Ratio | 10.43 | |||||
Price-to-Owner-Earnings | 59.22 | |||||
PS Ratio | 1.68 | |||||
PB Ratio | 0.83 | |||||
Price-to-Tangible-Book | 2.06 | |||||
Price-to-Free-Cash-Flow | 6.47 | |||||
Price-to-Operating-Cash-Flow | 6.47 | |||||
EV-to-EBIT | 9.25 | |||||
EV-to-Forward-EBIT | 10.85 | |||||
EV-to-EBITDA | 6.12 | |||||
EV-to-Forward-EBITDA | 8.03 | |||||
EV-to-Revenue | 2.07 | |||||
EV-to-Forward-Revenue | 1.87 | |||||
EV-to-FCF | 7.97 | |||||
Price-to-Projected-FCF | 2.21 | |||||
Price-to-Median-PS-Value | 0.54 | |||||
Price-to-Graham-Number | 1.47 | |||||
Earnings Yield (Greenblatt) % | 10.81 | |||||
FCF Yield % | 15.36 | |||||
Forward Rate of Return (Yacktman) % | -14.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LYPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Luye Pharma Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 859.147 | ||
EPS (TTM) ($) | 0.02 | ||
Beta | 0.01 | ||
Volatility % | 19.79 | ||
14-Day RSI | 14.61 | ||
14-Day ATR ($) | 0.000556 | ||
20-Day SMA ($) | 0.3094 | ||
12-1 Month Momentum % | -27.74 | ||
52-Week Range ($) | 0.3094 - 0.4282 | ||
Shares Outstanding (Mil) | 3,761.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Luye Pharma Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Luye Pharma Group Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Luye Pharma Group Ltd Frequently Asked Questions
What is Luye Pharma Group Ltd(LYPHF)'s stock price today?
When is next earnings date of Luye Pharma Group Ltd(LYPHF)?
Does Luye Pharma Group Ltd(LYPHF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |